Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses. Cashman KS, Mistry AM, Kesarwani A, De Andrade Costa A, et al. Neuro Oncol 2026 Feb 23:noag037. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Cashman KS, Mistry AM, Kesarwani A, De Andrade Costa A, et al. Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses. Neuro Oncol 2026 Feb 23:noag037. doi: 10.1093.
PMID: 41729934